Biogipuzkoa
Centro de investigación
![Foto de Biogipuzkoa](/img/uploaded/BB680065D0326B877226AAACFBE7F51A.png)
![Foto de University of Antwerp](/img/noimage_org.png)
University of Antwerp
Amberes, BélgicaPublicaciones en colaboración con investigadores/as de University of Antwerp (44)
2024
-
A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors
Alzheimer's Research and Therapy, Vol. 16, Núm. 1
-
Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 16, Núm. 2
-
Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results
Alzheimer's and Dementia, Vol. 20, Núm. 5, pp. 3525-3542
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
-
Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease
Computers in Biology and Medicine, Vol. 176
2023
-
CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs
Nature Medicine, Vol. 29, Núm. 5, pp. 1135-1145
-
Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))
Nature communications
-
Genetic Associations between Modifiable Risk Factors and Alzheimer Disease
JAMA Network Open, Vol. 6, Núm. 5
-
Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes
Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 36
-
Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Genome Medicine, Vol. 15, Núm. 1
-
PFAS levels and exposure determinants in sensitive population groups
Chemosphere, Vol. 313
-
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits
Alzheimer's and Dementia, Vol. 19, Núm. 6, pp. 2317-2331
2022
-
Association of Rare APOE Missense Variants V236E and R251G with Risk of Alzheimer Disease
JAMA Neurology, Vol. 79, Núm. 7, pp. 652-663
-
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease
Molecular neurodegeneration, Vol. 17, Núm. 1, pp. 27
-
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease (Molecular Neurodegeneration, (2022), 17, 1, (27), 10.1186/s13024-022-00521-3)
Molecular Neurodegeneration
-
Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 14, Núm. 1
-
Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset
Frontiers in Aging Neuroscience, Vol. 14
-
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Acta Neuropathologica, Vol. 144, Núm. 5, pp. 821-842
-
Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72
Brain Communications, Vol. 4, Núm. 4
-
New insights into the genetic etiology of Alzheimer's disease and related dementias
Nature genetics, Vol. 54, Núm. 4, pp. 412-436